EW Q3 2018 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q3 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$907M+10.4% YoY

Gross Profit

$686M75.7% margin

Operating Income

$255M28.2% margin

Net Income

$226M24.9% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

-3.9%

Cash Flow

Operating Cash Flow

$342M

Free Cash Flow

$260M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$6.0B

Total Liabilities

$2.6B

Stockholders' Equity

$3.4B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$907M	$822M	+10.4%
Gross Profit	$686M	$605M	+13.4%
Operating Income	$255M	$218M	+17.2%
Net Income	$226M	$170M	+32.8%

Revenue Segments

Transcatheter Heart Valves

$558M62%

Surgical Heart Valve Therapy

$185M20%

Critical Care

$164M18%

Geographic Segments

UNITED STATES

$519M57%

Europe

$201M22%

JAPAN

$94M10%

Rest of World

$92M10%